Past, Present, and Future Implantable Neuromodulation Treatments for Management of Urinary Urge Incontinence (UUI): Implications for Clinical Effectiveness and Safety
4 affiliations
- 1Neuspera Medical, Inc, 51 Dagget Dr, CA San Jose, 95134 USA
- 2Minnesota Urology, Woodbury, MN USA
- 3Department of Urology, Indiana University School of Medicine, Indianapolis, IN USA
- 4Department of Urology, Vanderbilt University Medical Center, Nashville, TN USA
Abstract
Purpose of the Review: This review examines the progress made in neuromodulation therapies for UUI since the original introduction of SNM devices until now. There are multiple current commercial neuromodulation therapies from which to choose, including those with sacral or tibial nerve targets. The intent is to provide critical evidence to help clinicians decide which device to offer their patients.
Recent Findings: Modern SNM systems consistently outperform both previous-generation SNM and contemporary iTNM. Modern SNM demonstrates substantially higher effectiveness than pooled averages including early device studies with outdated study designs, tools and implant techniques. Current iTNM outcomes are comparable to legacy SNM yet remain markedly lower than modern SNM.
Summary: Contemporary data supports a clear hierarchy—modern SNM offers the highest effectiveness and the most favorable safety profile. We believe that our field is moving toward minimally invasive, highly targeted, patient-directed SNM systems—an evolution that aligns with both clinical outcomes and patient preferences.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s11934-026-01377-6.
Related
- Patients’ Perspectives and Challenges with Sacral Neuromodulation Implantable Pulse Generator
- Analgesic Effectiveness of Ultrasound-Guided PECS II Block in Implantable Venous Port Catheter Placement: A Retrospective Comparative Study
- Effectiveness and safety of treatments for new-onset, refractory and relapsed vitreoretinal lymphoma: protocol for a systematic review and network meta-analysis.
- Long-term effectiveness of app-based therapy for female urinary incontinence: 48-week follow-up of a randomised controlled trial
- Cost-Effectiveness Analysis of Implantable Collamer Lens (ICL) Surgery Versus Contact Lens-Based Correction with Backup Spectacles in Young Adults-A Norwegian Societal Perspective.
BibTeX
@article{siegel2026past,
title = {{Past, Present, and Future Implantable Neuromodulation Treatments for Management of Urinary Urge Incontinence (UUI): Implications for Clinical Effectiveness and Safety}},
author = {Steven Siegel and Michael J Ehlert and Charles R. Powell and Melissa Kaufman},
journal = {Current Urology Reports},
year = {2026},
month = nov,
doi = {10.1007/s11934-026-01377-6},
url = {https://doi.org/10.1007/s11934-026-01377-6},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Past, Present, and Future Implantable Neuromodulation Treatments for Management of Urinary Urge Incontinence (UUI): Implications for Clinical Effectiveness and Safety
AU - Steven Siegel
AU - Michael J Ehlert
AU - Charles R. Powell
AU - Melissa Kaufman
PY - 2026
DA - 2026/11/04
JO - Current Urology Reports
DO - 10.1007/s11934-026-01377-6
UR - https://doi.org/10.1007/s11934-026-01377-6
AB - Purpose of the Review: This review examines the progress made in neuromodulation therapies for UUI since the original introduction of SNM devices until now. There are multiple current commercial neuromodulation therapies from which to choose, including those with sacral or tibial nerve targets. The intent is to provide critical evidence to help clinicians decide which device to offer their patients. Recent Findings: Modern SNM systems consistently outperform both previous-generation SNM and contemporary iTNM. Modern SNM demonstrates substantially higher effectiveness than pooled averages including early device studies with outdated study designs, tools and implant techniques. Current iTNM outcomes are comparable to legacy SNM yet remain markedly lower than modern SNM. Summary: Contemporary data supports a clear hierarchy—modern SNM offers the highest effectiveness and the most favorable safety profile. We believe that our field is moving toward minimally invasive, highly targeted, patient-directed SNM systems—an evolution that aligns with both clinical outcomes and patient preferences. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s11934-026-01377-6.
SN - 1527-2737
SN - 1534-6285
ER -